Vanda Pharmaceuticals
Price & Volume
Stats
See moreOpen | $4.91 |
Previous Close | $4.94 |
Day Range | $4.91-$5.15 |
52W Range | $3.46-$6.75 |
Market Cap | $314.8M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $190.8M |
Revenue Growth (YoY) | 22.8% |
Gross Profit (12 Mos) | $230.1M |
Diluted EPS | -$0.19 |
News
See moreYahoo Finance • 10 months ago
Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical Gastroenterology and Hepatology Journal
Yahoo Finance • last year
Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results
Yahoo Finance • 2 years ago
Q1 2023 Vanda Pharmaceuticals Inc Earnings Call
About
CEO | Dr. Mihael H. Polymeropoulos M.D. |
CFO | Mr. Kevin Patrick Moran |
Address | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 203 |
